Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 13, 2012
On determining the BMD from multiple outcomes in developmental toxicity studies when one outcome is intentionally missingJulie S Najita, Paul J CatalanoJournal of the Royal Statistical Society. Series C, Applied Statistics|April 2, 2010
A Novel Application of a Bivariate Regression Model for Binary and Continuous Outcomes to Studies of Fetal ToxicityJulie S Najita, Yi Li, Paul J CatalanoBreast (Edinburgh, Scotland)|January 29, 2013
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab eraErin M Olson, Julie S Najita, Jessica Sohl, et al.Cancer|September 5, 2009
Caring for cancer survivors: a survey of primary care physiciansSharon L Bober, Christopher J Recklitis, Eric G Campbell, et al.The Lancet. Oncology|July 17, 2013
Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohortSara E Barton, Julie S Najita, Elizabeth S Ginsburg, et al.Clinical Breast Cancer|September 11, 2014
Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancerErica L Mayer, Adrienne B Gropper, Lyndsay Harris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.Pageof 1